An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
Figure 1. Central role of Toll-like receptors in the tumor-microenvironment of pancreatic cancer. Kras-mutant epithelial…
Figure 1. Central role of Toll-like receptors in the tumor-microenvironment of pancreatic cancer. Kras-mutant epithelial cells attract immune cells, which, in turn, promote inflammation and cause stress and damage to pre-malignant epithelial cells. We postulate that epithelial cells may respond to stress by undergoing the process of oncogene-induced senescence (OIS), leading to upregulation of tumor-suppressor proteins such as p21, p27, p53 and pRB. Some of these cells will bypass the barrier of OIS and transform, whereas others will die and release DAMPs. DAMPs, in turn, can bind TLRs on immune cells, leading to worsening inflammation and completing a vicious circle. At the same time, inflammatory mediators such as IL-6 can directly signal to transformed cells and activate pathways such as STAT3 that promote an aggressive cancer phenotype featuring increased expression of oncoproteins such as c-Myc and Bcl-xL. Furthermore, cancer-associated fibroblasts can be activated by released DAMPs either directly or indirectly through the immune cells, causing intense fibrosis and further perpetuating inflammation. Toll-like receptors act as the sensors of the DAMPs and therefore participate in several of the above steps.
Ochi A, Graffeo CS, Zambirinis CP, Rehman A, Hackman M, Fallon N, et al.
Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans.
J Clin Invest. 2012;122:4118–29. doi: 10.1172/JCI63606.doi:10.1172/JCI63606
Ochi A, Nguyen AH, Bedrosian AS, Mushlin HM, Zarbakhsh S, Barilla R, et al.
MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.
J Exp Med. 2012;209:1671–87. doi: 10.1084/jem.20111706.doi:10.1084/jem.20111706
References
Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–20. doi: 10.1016/j.cell.2010.01.022.
-
DOI
-
PubMed
Rakoff-Nahoum S, Medzhitov R. Toll-like receptors and cancer. Nat Rev Cancer. 2009;9:57–63. doi: 10.1038/nrc2541.
-
DOI
-
PubMed
Ochi A, Graffeo CS, Zambirinis CP, Rehman A, Hackman M, Fallon N, et al. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans. J Clin Invest. 2012;122:4118–29. doi: 10.1172/JCI63606.
-
DOI
-
PMC
-
PubMed
Ochi A, Nguyen AH, Bedrosian AS, Mushlin HM, Zarbakhsh S, Barilla R, et al. MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp Med. 2012;209:1671–87. doi: 10.1084/jem.20111706.
-
DOI
-
PMC
-
PubMed
Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer. 2009;9:798–809. doi: 10.1038/nrc2734.
-
DOI
-
PMC
-
PubMed